StockData
DNA X, Inc. logo

DNA X, Inc. (SONM) stock

SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$2.38+0.10 (+4.39%)

Close on Nov 12, 2026Market cap $3.54MP/E –Yield –

DNA X ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

DNA X's ebitda for the twelve months ending Dec 31, 2025 was -$1.11M, down 342.0% year over year. For fiscal 2025 it was -$1.11M, down 342.0% from the year before. The highest annual figure on record is $7.24M in fiscal 2018.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.11M-342.0%
FY2024Dec 31, 2024$457.00K-83.2%
FY2023Dec 31, 2023$2.72M–
FY2022Dec 31, 2022-$11.92M–
FY2021Dec 31, 2021-$35.87M–
FY2020Dec 31, 2020-$26.53M–
FY2019Dec 31, 2019-$18.86M-360.3%
FY2018Dec 31, 2018$7.24M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$6.16M-34.1%
Q3 FY2025Sep 30, 2025-$3.03M–
Q2 FY2025Jun 30, 2025-$674.00K–
Q1 FY2025Mar 31, 2025$185.00K–
Q4 FY2024Dec 31, 2024$9.35M–
Q3 FY2024Sep 30, 2024-$1.46M-293.1%
Q2 FY2024Jun 30, 2024-$5.63M-532.7%
Q1 FY2024Mar 31, 2024-$1.81M-287.9%
Q4 FY2023Dec 31, 2023-$299.00K-139.3%
Q3 FY2023Sep 30, 2023$755.00K–
Q2 FY2023Jun 30, 2023$1.30M–
Q1 FY2023Mar 31, 2023$963.00K–
Q4 FY2022Dec 31, 2022$761.00K–
Q3 FY2022Sep 30, 2022-$1.76M–
Q2 FY2022Jun 30, 2022-$4.02M–
Q1 FY2022Mar 31, 2022-$6.89M–
Q4 FY2021Dec 31, 2021-$11.24M–
Q3 FY2021Sep 30, 2021-$10.14M–
Q2 FY2021Jun 30, 2021-$6.00M–
Q1 FY2021Mar 31, 2021-$8.50M–
Q4 FY2020Dec 31, 2020-$7.05M–
Q1 FY2020Mar 31, 2020-$8.17M–
Q4 FY2019Dec 31, 2019-$6.54M-208.3%
Q3 FY2019Sep 30, 2019-$5.39M-242.1%
Q2 FY2019Jun 30, 2019-$3.68M-482.8%
Q1 FY2019Mar 31, 2019-$3.25M–
Q4 FY2018Dec 31, 2018$6.04M–
Q3 FY2018Sep 30, 2018$3.79M–
Q2 FY2018Jun 30, 2018$960.00K–
Q1 FY2018Mar 31, 2018-$3.55M–

More DNA X figures

See a number that looks wrong?